Search results
AstraZeneca withdraws its COVID-19 vaccine from global market
The Hill via Yahoo News· 6 days agoAstraZeneca is withdrawing its COVID-19 vaccine from the market because of low demand, the drugmaker...
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 20 hours agoHere's a look at Novavax's deal with Sanofi to see if buying this stock now could be a smart move....
COVID-19 deaths increase to 4 in N.B., hospitalizations drop to 3, fewer than flu admissions
CBC via Yahoo News· 13 hours agoCOVID-19 deaths in New Brunswick doubled to four, week-over-week, while hospitalizations for or with...
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize ...
Benzinga· 5 days agoSanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID ...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 2 days agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel COVID-19
Meghan Markle and Prince Harry's foundation ordered to stop fundraising: What to know
Yahoo Celebrity· 13 hours agoCalifornia’s attorney general, Rob Bonta, sent a letter to the couple’s foundation stating it’s...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar
Motley Fool via Yahoo Finance· 2 days agoModerna Moderna is one of the captains of a sinking ship. As a leader in the COVID-19 vaccine...
New COVID-19 variant FLiRT detected in US. Here's what to know
The El Paso Times via Yahoo News· 7 days agoAccording to the CDC, only 22.6% of adults reported having received an updated 2023-24 COVID-19 ...
AstraZeneca to withdraw COVID vaccine globally as demand dips
Reuters· 7 days ago, opens new tab said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 2 days agoEarlier this month, along with its earnings release, Moderna reiterated its product revenue guidance...